Form 4 for DXCM Dexcom
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-08 · accession 0001093557-26-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-08 | DXCM | SAYER KEVIN R | Executive COB, Dir | F - Tax | $68.10 | -32.5K | 409.2K | -7% | -$2.21M | |
| 2026-03-10 | 2026-03-08 | DXCM | SAYER KEVIN R | Executive COB, Dir | A - Grant | $0.00 | +32.7K | 441.7K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-08 | F | D | 32,498 | $68.10 | 409,241 | D | — | — | (F2) Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. (F3) Included in this number are 106,972 unvested RSUs, 32,749 of which were granted on March 8, 2026 and shall vest on March 8, 2027, 56,993 of which were granted on March 8, 2025 and shall vest through March 8, 2028, and 17,230 of which were granted on March 8, 2024 and shall vest through March 8, 2027. |
| 2 | Common | Common Stock | 2026-03-08 | A | A | 32,749 | $0.00 | 441,739 | D | — | — | (F1) Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting on the one year anniversary of the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. |